US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist

2.050
+0.350+20.59%

Close Nov 29 13:00 ET

2.030
-0.020-0.98%

Post 17:01 ET

48.49MMarket Cap-348P/E (TTM)

Outlook Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Outlook Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Aug 14, 2024	2024/Q3	0.000 / 0.000	--
May 16, 2024	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Aug 14, 20242024/Q30.000 / 0.000--

May 16, 20242024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Outlook Therapeutics Earnings Reports

Outlook Therapeutics | 10-Q: Q3 2024 Earnings Report

Aug 14 16:21 ET

Outlook Therapeutics | 8-K: Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update

Aug 14 07:49 ET

Outlook Therapeutics | 10-Q: Q2 2024 Earnings Report

May 15 17:22 ET

Outlook Therapeutics | 8-K: Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

May 15 17:21 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall